Close
  Indian J Med Microbiol
 

Figure 1: Rifampicin susceptibility profile and CFU fold-change of M. smegmatis NCF and SCF exposed to 10× MBC rifampicin for 120 h. (a) The CFU of NCF and SCF plated on rifampicin-free and rifampicin plates (50× MBC) after exposure to 10× MBC rifampicin. (b and d) Fold-change in the CFU at specific 6-h intervals of (b) NCF and (d) SCF. The expected 4-fold increase in CFU in 6 h is indicated by the horizontal dotted line. (c and e) The CFU spurts at specific 6-h intervals of (c) NCF and (e) SCF. The spurts of CFU beyond the expected 4-fold in both the samples in 6-h periods are indicated in red box. n = 3 in all cases. MBC: Minimum bactericidal concentration, CFU: Colony forming unit, NCF: Normal-sized cells-enriched fraction, SCF: Short-sized cells-enriched fraction

Figure 1: Rifampicin susceptibility profile and CFU fold-change of <i>M. smegmatis</i> NCF and SCF exposed to 10× MBC rifampicin for 120 h. (a) The CFU of NCF and SCF plated on rifampicin-free and rifampicin plates (50× MBC) after exposure to 10× MBC rifampicin. (b and d) Fold-change in the CFU at specific 6-h intervals of (b) NCF and (d) SCF. The expected 4-fold increase in CFU in 6 h is indicated by the horizontal dotted line. (c and e) The CFU spurts at specific 6-h intervals of (c) NCF and (e) SCF. The spurts of CFU beyond the expected 4-fold in both the samples in 6-h periods are indicated in red box. <i>n</i> = 3 in all cases. MBC: Minimum bactericidal concentration, CFU: Colony forming unit, NCF: Normal-sized cells-enriched fraction, SCF: Short-sized cells-enriched fraction